Frank Cichocki Selected Research

NK Cell Lectin-Like Receptor Subfamily C

12/2021	Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.
1/2019	Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Cichocki Research Topics

Disease

12	Neoplasms (Cancer) 11/2022 - 10/2012
5	Infections 12/2021 - 03/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 03/2012
1	Lymphoma (Lymphomas) 01/2022
1	Vaccinia 01/2022
1	Multiple Myeloma 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Cerebral Malaria 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2016
1	Residual Neoplasm 01/2016
1	Inflammation (Inflammations) 03/2014
1	Leukemia 10/2012

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2022 - 01/2016
3	CytokinesIBA 11/2020 - 03/2014
2	VaccinesIBA 11/2022 - 01/2022
2	NK Cell Lectin-Like Receptor Subfamily CIBA 12/2021 - 01/2019
1	micaIBA 11/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	ChemokinesIBA 03/2014
1	KIR ReceptorsIBA 10/2012
1	LigandsIBA 10/2012
1	Antiviral Agents (Antivirals)IBA 10/2012
1	Interleukin-12 (IL 12)IBA 03/2012

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2016
4	Immunotherapy 11/2020 - 10/2017
3	Cell Transplantation 01/2021 - 03/2014
1	Autologous Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 01/2016
1	Stem Cell Transplantation 10/2012